GLP-1s (glucagon-like peptide-1 receptor agonists) mimic a hormone naturally produced in your gut
Clinical trials reveal that stopping semaglutide after a few months often leads to weight regain, making ongoing, personalized therapy a more effective strategy than temporary treatment courses
In the UK, commonly prescribed GLP-1 medications include semaglutide (Ozempic for diabetes, Wegovy for weight management), liraglutide (Victoza for diabetes, Saxenda for weight management), dulaglutide (Trulicity for diabetes), and tirzepatide (Mounjaro for diabetes), which is a dual GLP-1 and GIP receptor agonist
This condition can create numerous chronic problems increasing employee medical and pharmacy costs while lowering productivity
Administrative Delays and Policy Loopholes Some insurers delay, hiding behind technicalities such as dates, forms, or network-level mismatches